177 related articles for article (PubMed ID: 16078599)
1. [Cardiorenal pathology in diabetes mellitus type 1: mechanisms of development and medical correction].
Shestakov MV; Iarek-Martynova IR; Kukharenko SS; Aleksandrov AA; Dedov II
Ter Arkh; 2005; 77(6):40-5. PubMed ID: 16078599
[TBL] [Abstract][Full Text] [Related]
2. Role of endothelial dysfunction in the development of cardiorenal syndrome in patients with type 1 diabetes mellitus.
Shestakova MV; Jarek-Martynowa IR; Ivanishina NS; Kuharenko SS; Yadrihinskaya MN; Aleksandrov AA; Dedov II
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S65-72. PubMed ID: 15955379
[TBL] [Abstract][Full Text] [Related]
3. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients.
Kaiser T; Heise T; Nosek L; Eckers U; Sawicki PT
J Hypertens; 2006 Jul; 24(7):1397-403. PubMed ID: 16794490
[TBL] [Abstract][Full Text] [Related]
4. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
Pronko TP; Zinchuk VV
Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
[TBL] [Abstract][Full Text] [Related]
5. [Cardiorenal syndrome in type 1 diabetes mellitus: the role of endothelial dysfunction].
Shestakova MV; Iarek-Martynova IR; Ivanishina NS; Aleksandrov AA; Dedov II
Kardiologiia; 2005; 45(6):35-41. PubMed ID: 16007033
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
[TBL] [Abstract][Full Text] [Related]
7. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
[TBL] [Abstract][Full Text] [Related]
8. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
9. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
[TBL] [Abstract][Full Text] [Related]
10. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
de Boer RA; Doehner W; van der Horst IC; Anker SD; Babalis D; Roughton M; Coats AJ; Flather MD; van Veldhuisen DJ;
Am J Cardiol; 2010 Jul; 106(1):78-86.e1. PubMed ID: 20609652
[TBL] [Abstract][Full Text] [Related]
11. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
[TBL] [Abstract][Full Text] [Related]
12. [Administration of cardioselective beta-adrenoblockers in patients with arterial hypertension and/or ischemic heart disease associated with bronchoobstructive syndrome].
Ovcharenko SI; Litvinova IV; Mikolkin VI
Ter Arkh; 2007; 79(9):12-8. PubMed ID: 18038580
[TBL] [Abstract][Full Text] [Related]
13. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
[TBL] [Abstract][Full Text] [Related]
15. [Nebivolol effects on the cardiovascular system and the kidneys in pregnant and puerperal women with hypertension].
Tkacheva ON; Vertkin AL; Barabashkina AV; Vasil'eva AV; Razguliaeva NF
Ter Arkh; 2006; 78(10):56-61. PubMed ID: 17180940
[TBL] [Abstract][Full Text] [Related]
16. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
Barri YM; Palmer BF; Ram CV
Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
Shestakova MV; Koshel' LV; Vagodin VA; Dedov II
Ter Arkh; 2006; 78(5):60-4. PubMed ID: 16889052
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
19. [Effects of a superselective beta1-adrenoblocker nebivolol on the course of coronary heart disease and insulin resistance in patients with diabetes mellitus type 2 after coronary artery bypass grafting].
Tepliakov AT; Kuznetsova AV; Lukinov AV; Levshin AV
Ter Arkh; 2007; 79(12):38-43. PubMed ID: 18220029
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
Buval'tsev VI; Spasskaia MB; Nebieridze DV; Metel'skaia VA; Guseva OI
Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
